Overview
Distal deletion 13q syndrome (also known as distal monosomy 13q or 13q deletion syndrome, distal type) is a rare chromosomal disorder caused by a partial deletion of the long arm (q arm) of chromosome 13, specifically involving the distal (far end) region. The size and exact location of the deleted segment can vary among affected individuals, which leads to a wide spectrum of clinical severity. This condition is typically identified at birth or during early childhood based on characteristic clinical features. The syndrome affects multiple body systems. Key clinical features include intellectual disability of variable severity, growth retardation, craniofacial dysmorphisms (such as microcephaly, a broad nasal bridge, a short nose, micrognathia, and low-set ears), and limb anomalies. Notably, deletions involving the 13q32 region are frequently associated with more severe manifestations, including holoprosencephaly (a brain malformation where the forebrain fails to divide properly), eye abnormalities (microphthalmia, coloboma, or anophthalmia), and genital anomalies in males (hypospadias, cryptorchidism). Congenital heart defects and gastrointestinal malformations such as Hirschsprung disease may also occur. Distal 13q deletions that include the retinoblastoma gene (RB1) locus at 13q14 may predispose to retinoblastoma, though this is more characteristic of proximal deletions. There is no cure for distal deletion 13q syndrome. Management is supportive and multidisciplinary, tailored to the individual's specific clinical manifestations. This may include surgical correction of congenital anomalies (cardiac, gastrointestinal, or craniofacial), early intervention programs, speech and occupational therapy, and regular ophthalmologic and developmental assessments. Genetic counseling is recommended for affected families to assess recurrence risk, as most cases arise de novo, though parental chromosomal rearrangements (such as balanced translocations) can increase the risk of recurrence.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Distal deletion 13q syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Distal deletion 13q syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Distal deletion 13q syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Distal deletion 13q syndrome.
Community
No community posts yet. Be the first to share your experience with Distal deletion 13q syndrome.
Start the conversation →Latest news about Distal deletion 13q syndrome
No recent news articles for Distal deletion 13q syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Distal deletion 13q syndrome
What is Distal deletion 13q syndrome?
Distal deletion 13q syndrome (also known as distal monosomy 13q or 13q deletion syndrome, distal type) is a rare chromosomal disorder caused by a partial deletion of the long arm (q arm) of chromosome 13, specifically involving the distal (far end) region. The size and exact location of the deleted segment can vary among affected individuals, which leads to a wide spectrum of clinical severity. This condition is typically identified at birth or during early childhood based on characteristic clinical features. The syndrome affects multiple body systems. Key clinical features include intellectu
At what age does Distal deletion 13q syndrome typically begin?
Typical onset of Distal deletion 13q syndrome is neonatal. Age of onset can vary across affected individuals.